JUN 25, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Naproxen Sodium (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for naproxen sodium labeling; describes a regulatory action, not clinical evidence of efficacy or safety.
Reported
Approval date2026-06-25
Dosage strength 1NAPROXEN SODIUM EQ 250MG BASE
Dosage strength 2NAPROXEN SODIUM EQ 500MG BASE